DCM
ALXO icon

Driehaus Capital Management’s ALX Oncology ALXO Stock Holding History

Driehaus Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Buy
6,025,240
+290,620
+5% +$520K 0.07% 266
2026
Q1 		$11.5M Buy
5,734,620
+4,311,738
+303% +$8.21M 0.08% 259
2025
Q4 		$1.61M Buy
1,422,882
+627,105
+79% +$950K 0.01% 339
2025
Q3 		$1.46M Buy
+795,777
New +$689K 0.01% 361

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Driehaus Capital Management's ALXO Position: Q2 2026 in Review

Driehaus Capital Management increased its ALX Oncology (ALXO) stake by 5.1% in Q2 2026, buying an estimated $520K and bringing the position to 6,025,240 shares worth $12.5M. The position accounts for 0.07% of the portfolio, ranked #266.

Driehaus Capital Management first reported a position in ALXO in Q3 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Driehaus Capital Management held 6,025,240 shares of ALX Oncology worth $12.5M as of Q2 2026.
  • Driehaus Capital Management bought 290,620 ALX Oncology shares in Q2 2026, an estimated $520K.
  • ALX Oncology made up 0.07% of Driehaus Capital Management's portfolio in Q2 2026, its #266 holding.
  • Driehaus Capital Management first reported a position in ALX Oncology in Q3 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.